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Objectives. The present study examined whether angina 48 h
before myocardial infarction provides protection in adult and
elderly patients.
Background. The mortality rate for coronary artery disease is
greater in elderly than in young patients. In experimental studies,
ischemic preconditioning affords an endogenous form of protec-
tion against ischemia–reperfusion injury in adult but not in
senescent hearts. Angina before myocardial infarction, a clinical
equivalent of experimental ischemic preconditioning, has a pro-
tective effect in adult patients. It is not known whether angina
before myocardial infarction is also protective in aged patients.
Methods. We retrospectively verified whether antecedent an-
gina within 48 h of myocardial infarction exerts a beneficial effect
on in-hospital outcomes in adult (<65 years old, n 5 293) and
elderly (>265 years old, n 5 210) patients.
Results. In-hospital death was more frequent in adult patients
without than in those with previous angina (10% vs. 2.6%, p <
0.01), as were congestive heart failure or shock (10.7% vs. 3.3%,
p < 0.02) and the combined end points (in-hospital death and
congestive heart failure or shock) (20.7% vs. 5.9%, p < 0.0003). In
contrast, the presence or absence of previous angina before acute
myocardial infarction in elderly patients seems not to influence
the incidence of in-hospital death (14.4% vs. 15.2%, p 5 0.97),
congestive heart failure or shock (11.0% vs. 11.9%, p 5 0.99) and
the combined end points (25.4% vs. 27.1%, p 5 0.89). Logistic
regression analysis models for in-hospital end points show that
previous angina is a positive predictor in adult but not in elderly
patients.
Conclusions. The presence of angina before acute myocardial
infarction seems to confer protection against in-hospital outcomes
in adults; this effect seemed to be less obvious in elderly patients.
This study suggests that the protection afforded by angina in adult
patients may involve the occurrence of ischemic preconditioning,
which seems to be lost in senescent patients.
(J Am Coll Cardiol 1997;30:947–54)
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Death due to coronary artery disease increases progressively
with age (1–6). In the United States, 80% of deaths from
coronary artery disease occur among patients .65 years (6).
Tofler et al. (7) showed that 7 adverse baseline and 12
additional in-hospital characteristics did not account for the
increased mortality rate of elderly patients in either in-hospital
or 1- or 4-year hospital survivors. The increased incidence of
death in elderly patients may be the result of the reduction of
thrombolytic therapy because of a higher incidence of compli-
cating illness, absence of chest pain on admission and nonspe-
cific electrocardiographic (ECG) abnormalities (8). Maggioni
et al. (9) demonstrated that age is a powerful independent
predictor of both in-hospital and postdischarge mortality rates
in patients with a first myocardial infarction who received
thrombolytic therapy, and they excluded a correlation between
age-related higher mortality for myocardial infarction and
more extensive coronary artery disease. They found that the
number and degree of critical coronary stenoses did not differ
according to age group in 20% of patients who died during the
hospital period and underwent autopsy.
Experimental studies demonstrated that preconditioning
myocardium through brief ischemic episodes before a pro-
longed coronary occlusion protects the heart by delaying lethal
injury, including postischemic electrical and mechanical dys-
function (10). Patients with myocardial infarction presenting
with prodromal angina have a significantly smaller infarct size
(11) and a better in-hospital outcome (12) than patients
without prodromal symptoms. Although the presence of an-
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gina before myocardial infarction may be a marker of a more
extensive coronary collateral circulation, these reports suggest
that ischemic preconditioning plays a role in the better prog-
nosis of patients with a myocardial infarction. We recently
demonstrated (13) that ischemic preconditioning significantly
reduces electromechanical postischemic dysfunction in adult
but not in senescent rat hearts, suggesting that age-related
reduction of this endogenous mechanism may be responsible
for the higher mortality observed in aging patients with myo-
cardial infarction.
We performed a retrospective analysis of the effect of
previous angina 48 h before acute myocardial infarction on
several in-hospital end points, including mortality, congestive
heart failure and cardiogenic shock, in patients $65 years old
compared with those ,65 years old.
Methods
Patients. Between January 1993 and December 1995, 530
patients with an acute myocardial infarction were admitted to
our coronary care unit; 298 were ,65 years old, and 232 were
$65 years old. Patients were included in this retrospective
study if they had at least two of the following criteria: 1) typical
chest pain; 2) ECG changes with evolution of Q waves
(transmural infarction); and 3) elevation of creatine kinase
(CK) levels. Nontransmural infarction was diagnosed by typi-
cal changes in ST segments and T waves accompanied by
increased CK levels. We recorded data from the history,
physical examination, laboratory studies, echocardiographic
variables and the ECG. Family history was considered positive
when symptomatic coronary artery disease occurred before age
60 in siblings, parents, parents’ siblings or grandparents. Pa-
tients with documented systolic blood pressure $160 mm Hg
or diastolic blood pressure $100 mm Hg and those taking
antihypertensive drugs were considered hypertensive. A previ-
ous myocardial infarction was documented by ECG or hospital
records. Other historical variables were history of congestive
heart failure (shortness of breath on exertion associated with
either orthopnea or paroxysmal nocturnal dyspnea), history of
diabetes, hypercholesterolemia (.200 mg/dl), smoking and
low educational level (,8 years). Information on the adminis-
tration of digitalis, diuretic drugs, nitrates, calcium antagonists,
beta-adrenergic blocking agents, angiotensin-converting en-
zyme inhibitors and aspirin was recorded at admission. Throm-
bolytic therapy was given to all patients except those presenting
with complicating illness, absence of chest pain on admission
or nonspecific ECG abnormalities, including ST segment de-
pression. Age $65 years was not considered a contraindication
for thrombolytic therapy. All patients $65 years old with an
acute myocardial infarction were admitted to our coronary
care unit regardless of functional status. Patients with ad-
vanced or terminal illness, cerebrovascular disease and such
neuropsychiatric disorders as dementia and delirium were not
included in the study. In particular, among patients ,65 years
old, two (0.7%) with terminal illness and three (1.0%) with
cerebrovascular disease were excluded. Among patients $65
years old, 6 (2.5%) with terminal illness, 6 (2.6%) with
cerebrovascular disease and 10 (4.3%) with dementia were
excluded. In our coronary care unit, patients with suspected
cerebrovascular disease or dementia are immediately exam-
ined by a consultant neurologist (available 24 h/day for all
clinical departments) to confirm or exclude these conditions.
The criteria for the diagnosis of dementia are memory impair-
ment and one or more neurologic disturbances (aphasia,
apraxia, agnosia, disturbance in executive functioning), as
described in Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV, American Psychiatric Association).
The following ECG variables were determined: presence or
absence of ventricular tachycardia and fibrillation; atrial fibril-
lation and flutter; atrial and junctional tachycardia; bundle
branch block; intraventricular conduction delay; and first,
second or complete heart block. We also used continuous ECG
monitoring to analyze complex ventricular arrhythmias when
present and defined them as frequent ventricular beats (.1
beat/min or 30 beats/h), multiform ventricular premature
beats, couplets and ventricular tachycardia (.3 premature
ventricular beats). These ECG variables were monitored dur-
ing the entire clinical course.
Blood samples for assay of CK and CK-MB plasma levels
were taken on admission and 8, 16 and 24 h after enrollment.
The upper limits of normal range in our laboratory are 160 and
12.8 IU/liter for plasma CK and CK-MB, respectively. The
time to CK-MB peak levels was measured from the onset of
myocardial infarction symptoms.
Major in-hospital end points in the coronary care unit were
death, congestive heart failure (presence of rales that do not
clear with coughing over .50% of the lung field and radio-
graphic confirmation of pulmonary congestion) and cardio-
genic shock; minor end points were infarct extension, persis-
tent chest pain (.30 min), CK-MB peak level, CK-MB time to
peak level, ventricular fibrillation and tachycardia ($3 consec-
utive premature ventricular complexes), high grade atrioven-
tricular block, left ventricular dysfunction (after the fourth
hospital day, indicated by the presence of an S3 gallop, rales or
radiographic evidence of pulmonary congestion or as extensive
left ventricular injury in the absence of clinical heart failure
[indicated by left ventricular ejection fraction #35% on echo-
cardiography] or as injury to $45% of myocardial segments
[akinetic–dyskinetic scores]) (14). Left ventricular ejection
fraction was available only in 83 adult and 52 elderly patients
(28.3% and 24.7%, respectively).
Analysis of previous angina. A staff physician collected a
detailed clinical history for all patients. Patients who had not
experienced chest pain, chest discomfort or left arm and jaw
Abbreviations and Acronyms
CK 5 creatine kinase
CK-MB 5 creatine kinase, MB fraction
ECG 5 electrocardiographic
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pain 48 h before the episode leading to admission were defined
as having “no previous angina.” Patients showing angina
lasting ,30 min 48 h before the acute myocardial infarction
were defined having “previous angina.” Patients with a history
of angina at any time independently by the presence or absence
of angina 48 h before the acute myocardial infarction were
defined having “chronic angina.”
Statistical analysis. Categoric data were compared with
chi-square analyses. The Student t test was used to compare
continuous variables such as age. Logistic regression models
were used to assess the role of previous angina in death,
congestive heart failure and cardiogenic shock and the com-
bined end points unadjusted and simultaneously adjusted for
thrombolytic therapy, antianginal treatment and demographic
variables (age, gender, family history, low educational level,
smoking, chronic angina, previous myocardial infarction, con-
gestive heart failure, hypertension, diabetes and cholesterol-
emia). A p value of 0.05 was considered significant.
Results
Baseline characteristics. Adult (,65 years old) and elderly
patients ($65 years old) differed with regard to age, gender,
educational level, smoking and hypercholesterolemia (Table
1). However, there was no difference in family history, chronic
angina, previous myocardial infarction, hypertension, history
of heart failure, diabetes, antianginal therapy and clinical
symptoms of heart failure.
Age, gender, family history, sedentary lifestyle and low
educational level did not differ between adult patients with
versus without angina before acute myocardial infarction.
More adult patients with angina had an antecedent myocardial
infarction (p , 0.0001), and more took antianginal medicines
(nitrates: p , 0.0001; calcium channel blocking agents: p 5
0.001) and aspirin (p , 0.00001). There was no difference in
history of smoking, hypertension, heart failure, diabetes and
hypercholesterolemia. More elderly patients with previous
angina had an antecedent myocardial infarction (p , 0.001),
and more took antianginal drugs (nitrates: p , 0.0001; calcium
blockers: p , 0.003) and aspirin (p , 0.004) than those without
previous angina.
In-hospital outcome. As shown in Table 2, in-hospital
death was more frequent in adult patients without than in
those with a previous history of angina (10% vs. 2.6%, p ,
0.01). Congestive heart failure or shock (10.7% vs. 3.3%, p ,
0.05) and the combined end points (in-hospital death and
congestive heart failure or shock: 20.7% vs. 5.9%, p , 0.0003)
were more frequent in adult patients without than in those with
previous angina before acute myocardial infarction (Fig. 1).
However, in elderly patients the presence or absence of
previous angina before an acute myocardial infarction seems
not to influence the occurrence of in-hospital death (p 5 0.97),
congestive heart failure or shock (p 5 0.99) and the combined
end points (p 5 0.89) (Table 3, Fig. 1).
Similarly, adult patients with angina were less likely to have
a Q wave myocardial infarction and ventricular fibrillation and
had a lower CK-MB release and a lower incidence of left
ventricular dysfunction than those without angina (Table 2).
These in-hospital end points were similar in elderly patients
with and without angina (Table 3). Time to lytic therapy ($4 h)
Table 1. Baseline Characteristics of Adult (,65 years old) and
Elderly ($65 years old) Patients With Acute Myocardial Infarction
Adult
Patients
(n 5 293)
Elderly
Patients
(n 5 210)
p
Value
Age 52.7 6 9.2 74.1 6 7.1 0.01
Male 256 (87.4) 138 (63.2) 0.0000
Family history 83 (28.3) 56 (26.9) 0.75 (NS)
Low educational level 198 (67.5) 174 (82.7) 0.0001
Chronic angina 101 (34.5) 69 (33.0) 0.77 (NS)
Previous MI 74 (25.2) 47 (22.5) 0.52 (NS)
Smoking 241 (82.3) 129 (61.5) 0.0000
Hypertension 106 (36.3) 92 (43.9) 0.10 (NS)
CHF 36 (12.2) 27 (13.0) 0.95 (NS)
Diabetes 80 (27.3) 64 (30.5) 0.49 (NS)
Hypercholesterolemia 98 (33.6) 28 (13.1) 0.0000
Nitrates 47 (16.0) 46 (22.0) 0.12 (NS)
Beta-blockers 16 (5.4) 7 (3.3) 0.36 (NS)
Calcium blockers 62 (21.0) 56 (26.5) 0.18 (NS)
Aspirin 37 (12.6) 35 (16.5) 0.25 (NS)
S3 sounds 33 (11.4) 19 (9.1) 0.51 (NS)
Rales .1⁄3 lung fields 23 (7.8) 17 (8.0) 0.94 (NS)
Data presented are mean value 6 SD or number (%) of patients. CHF 5
congestive heart failure; MI 5 myocardial infarction.
Table 2. In-Hospital Outcomes of Adult Patients (,65 years old)
With or Without Previous Angina 48 Hours Before Acute
Myocardial Infarction
In-Hospital End Points
Previous Angina
p
Value
Yes
(n 5 153)
No
(n 5 140)
In-hospital death 4 (2.6) 14 (10.0) 0.01
CHF 5 (3.3) 15 (10.7) 0.02
Death or CHF 9 (5.9) 29 (20.7) 0.0003
Lytic therapy 72 (46.8) 58 (41.2) 0.39 (NS)
Time to lytic therapy
$4 h 63 (41.0) 55 (39.5) 0.83 (NS)
.4 h 10 (6.8) 6 (4.1) 0.55 (NS)
t-PA 53 (34.7) 36 (25.6) 0.12 (NS)
Urokinase 23 (15.0) 24 (16.9) 0.73 (NS)
In-hospital reinfarction 14 (9.1) 9 (6.5) 0.51 (NS)
Recurrent ischemic pain 21 (13.5) 13 (9.5) 0.31 (NS)
Q wave MI 95 (62.1) 103 (73.5) 0.04
CK-MB peak (IU/liter) 117 6 79 219 6 95 0.01
Time to peak CK (min) 10.5 6 3.4 9.8 6 3.1 0.42 (NS)
Ventricular fibrillation 5 (3.0) 13 (9.2) 0.05
Ventricular tachycardia 44 (29.0) 52 (37.0) 0.16 (NS)
High grade AV block 9 (6.0) 13 (9.2) 0.37 (NS)
LV dysfunction 20 (13.0) 32 (22.8) 0.04
Data presented are mean value 6 SD or number (%) of patients. AV 5
atrioventricular; CK 5 creatine kinase; CK-MB 5 creatine kinase, MB fraction;
LV 5 left ventricular; t-PA 5 tissue-type plasminogen activator; other abbrevi-
ations as in Table 1.
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and lytic therapy (recombinant tissue-type plasminogen activa-
tor or urokinase) was similar in adult patients with and without
angina (Table 2). Thrombolytic therapy was given in fewer
elderly than adult patients (25.7% vs. 44.3%, p , 0.005) and in
fewer elderly patients without than with angina (15.2% vs.
34.1%, p , 0.003) (Table 3).
The percentage of patients with chronic angina presenting
with symptoms 48 h before the acute myocardial infarction was
51.4% in patients ,65 years old and 55.8% in patients $65
years old (p 5 0.87). There was no significant difference in end
points between patients with or without a history of chronic
angina in either the elderly or the younger group.
Logistic regression models for death and congestive heart
failure or shock. To assess the role of previous angina we
performed logistic regression analysis with death, congestive
heart failure or shock and the combined end points (in-hospital
death and congestive heart failure or shock) as dependent
variables. The unadjusted model (Table 4) shows the protec-
tive role of previous angina in adult but not in elderly patients.
However, thrombolytic therapy was performed less frequently
Figure 1. Percentage of in-hospital death; congestive heart failure
(CHF) or shock; and in-hospital death and congestive heart failure or
shock in adult (,65 years old) and elderly patients ($65 years old)
with (open bars) or without (solid bars) previous angina 48 h before
acute myocardial infarction. *p , 0.01, **p , 0.02, ***p , 0.0003
versus angina.
Table 3. In-Hospital Outcomes of Elderly Patients ($65 years old)
With or Without Previous Angina 48 Hours Before Acute
Myocardial Infarction
In-Hospital End Points
Previous Angina
p
Value
Yes
(n 5 118)
No
(n 5 92)
In-hospital death 17 (14.4) 14 (15.2) 0.97 (NS)
CHF 13 (11.0) 11 (11.9) 0.99 (NS)
Death or CHF 30 (25.4) 25 (27.1) 0.89 (NS)
Lytic therapy 40 (34.1) 14 (15.2) 0.003
Time to lytic therapy
#4 h 30 (25.6) 13 (14.1) 0.04
.4 h 11 (9.4) 1 (0.9) 0.01
t-PA 25 (21.6) 9 (10.2) 0.02
Urokinase 16 (13.2) 7 (7.9) 0.25 (NS)
In-hospital reinfarction 6 (5.4) 6 (7.1) 0.88 (NS)
Recurrent ischemic pain 14 (12.0) 11 (11.7) 0.84 (NS)
Q wave MI 78 (66.5) 65 (70.5) 0.58 (NS)
CK-MB peak (IU/liter) 221 6 95 236 6 141 0.82 (NS)
Time to peak CK (min) 12.1 6 3.6 11.9 6 4.6 0.73 (NS)
Ventricular fibrillation 8 (7.1) 8 (8.5) 0.79 (NS)
Ventricular tachycardia 30 (25.6) 28 (30.2) 0.51 (NS)
High grade AV block 15 (12.7) 13 (13.8) 0.92 (NS)
LV dysfunction 20 (17.0) 15 (16.8) 0.95 (NS)
Data presented are mean value 6 SD or number (%) of patients. Abbrevi-
ations as in Table 2.
Table 4. Protective Role of Angina 48 Hours Before Acute Myocardial Infarction in Adult and Elderly Patients: Unadjusted Regression
Model for In-Hospital Death and Congestive Heart Failure or Shock and Combined End Points (in-hospital death, congestive heart failure
or shock)
Adult Elderly
Chi-Square OR (95% CI)
p
Value Chi-Square OR (95% CI)
p
Value*
In-hospital death 5.69 0.24 (0.07–0.81) 0.01 0.00 0.94 (0.41–2.16) 0.97
CHF or shock 5.26 0.28 (0.09–0.86) 0.02 0.00 0.91 (0.36–2.32) 0.99
Death and CHF or shock 12.96 0.24 (0.10–0.55) 0.0003 0.02 0.91 (0.47–1.78) 0.90
*p 5 NS for all comparisons. CHF 5 congestive heart failure; CI 5 confidence interval; OR 5 odds ratio.
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in elderly than in adult patients, and among elderly patients
less frequently in those without than in those with previous
angina. Antianginal therapy in patients with previous angina
should improve in-hospital end points. In addition, demo-
graphic variables such as previous myocardial infarction, which
was more frequent in both age groups with previous angina,
can also affect the results. Therefore, we performed a logistic
regression analysis with simultaneous adjustment for lytic
therapy, antianginal drugs and demographic variables to eval-
uate the protective role of angina regardless of these possible
confounding variables (Table 5). This analysis also confirmed
the protective role of previous angina in adult but not elderly
patients. In particular, as shown in Table 6, the only predictive
variable for “in-hospital mortality” is the previous angina in
adult patients, whereas only age is predictive in elderly pa-
tients. However, our logistic regression model is influenced by
the presence of variables such as history of previous myocar-
dial infarction, hypertension or congestive heart failure. In the
absence of these variables, the odds ratio for previous angina is
0.11 (95% confidence interval 0.02 to 0.58, chi-square 6.72, p ,
0.01), which is a value close to that observed in the unadjusted
model. A possible interpretation is that the history of previous
myocardial infarction, hypertension and congestive heart fail-
ure makes the previous angina even more protective than in
their absence.
Discussion
The present study suggests that in adult patients (,65 years
old), previous angina 48 h before acute myocardial infarction is
responsible for the lower occurrence of in-hospital death,
congestive heart failure or shock and combined end points
when compared with patients without previous angina. The
protective effect of previous angina was unrelated to the use of
thrombolytic therapy and antianginal drugs and demographic
variables such as a previous myocardial infarction. Surpris-
ingly, previous angina seems to lose its protective effect in
elderly patients ($65 years old). The presence of previous
Table 5. Protective Role of Angina 48 Hours Before Acute Myocardial Infarction in Adult and Elderly Patients: Adjusted Regression Model
for In-Hospital Death and Congestive Heart Failure or Shock and Combined End Points (in-hospital death, congestive heart failure
or shock)*
Adult Elderly
Chi-Square OR (95% CI)
p
Value Chi-Square OR (95% CI)
p
Value†
In-hospital death 9.27 0.04 (0.005–0.32) 0.002 1.48 0.49 (0.15–1.90) 0.22
CHF or shock 4.95 0.20 (0.04–0.82) 0.02 1.82 0.42 (0.11–1.48) 0.18
Death and CHF or shock 10.84 0.13 (0.03–0.43) 0.001 0.57 0.63 (0.19–2.08) 0.45
*The models were simultaneously adjusted for thrombolytic therapy, antianginal therapy and several variables, including age, gender, family history, low education
level, smoking, chronic angina, previous myocardial infarction, congestive heart failure (CHF), hypertension, diabetes and cholesterolemia. †p 5 NS for all comparisons.
Other abbreviations as in Table 4.
Table 6. Multivariate Analysis Including All Variables for In-Hospital Mortality in Adult (,65 years old) and Elderly Patients ($65 years old)
Adult Elderly
Chi-Square OR (95% CI)
p
Value Chi-Square OR (95% CI)
p
Value
Previous angina 9.27 0.04 (0.005–0.32) 0.002 1.47 0.49 (0.15–1.56) 0.225 (NS)
Age 0.04 0.97 (0.90–1.06) 0.620 (NS) 16.02 1.17 (1.08–1.27) 0.001
Chronic angina 0.07 0.80 (0.15–4.12) 0.789 (NS) 0.02 1.08 (0.39–2.95) 0.882 (NS)
Gender 1.48 0.33 (0.05–1.93) 0.223 (NS) 0.24 1.28 (0.48–3.39) 0.622 (NS)
Previous MI 2.19 3.71 (0.65–21.07) 0.138 (NS) 0.44 0.60 (0.13–2.67) 0.505 (NS)
Thrombolytic therapy 0.10 0.77 (0.16–3.53) 0.741 (NS) 0.56 0.57 (0.13–2.42) 0.452 (NS)
CHF 2.98 5.28 (0.79–35.03) 0.084 (NS) 0.00 0.98 (0.20–4.74) 0.982 (NS)
Hypertension 2.59 5.18 (0.28–11.44) 0.107 (NS) 0.01 1.07 (0.35–3.27) 0.899 (NS)
Diabetes 0.39 1.80 (0.28–5.78) 0.531 (NS) 1.05 1.75 (0.60–5.10) 0.304 (NS)
Family history 0.10 1.28 (0.30–6.33) 0.745 (NS) 0.05 0.87 (0.28–2.72) 0.819 (NS)
Low educational level (,8 yr) 0.74 2.75 (0.27–27.26) 0.386 (NS) 0.00 0.95 (0.24–3.81) 0.948 (NS)
Smoking 0.00 1.00 (0.48–2.11) 0.986 (NS) 0.97 1.42 (0.71–2.85) 0.325 (NS)
Nitrate 0.14 0.62 (0.05–6.94) 0.704 (NS) 0.12 0.79 (0.21–2.91) 0.718 (NS)
Beta-blocker 0.06 1.47 (0.07–28.11) 0.796 (NS) 0.07 0.70 (0.06–7.99) 0.777 (NS)
Calcium antagonist 1.35 2.81 (0.49–16.12) 0.245 (NS) 0.87 1.85 (0.51–6.73) 0.350 (NS)
Aspirin 0.00 1.08 (0.09–12.90) 0.949 (NS) 0.01 0.92 (0.27–3.22) 0.899 (NS)
Cholesterol (10-mg increase) 0.70 0.95 (0.30–2.95) 0.402 (NS) 0.02 0.99 (0.99–1.01) 0.882 (NS)
Abbreviations as in Tables 1 and 4.
951JACC Vol. 30, No. 4 ABETE ET AL.
October 1997:947–54 LOSS OF PRECONDITIONING IN AGING HEART
angina, in fact, represents a protective variable against these
in-hospital outcomes in the adult; this effect seems to be less
marked in elderly patients. CK-MB peak, number of Q wave
myocardial infarctions, ventricular fibrillation and left ventric-
ular dysfunction were significantly higher in adult patients
without than in those with angina before acute myocardial
infarction. These findings demonstrate that in adult patients
the absence of angina before acute myocardial infarction
represents a risk factor for myocardial infarction-induced
electromechanical modifications. In elderly patients previous
angina loses to some extent its protective role: The occurrence
of in-hospital death, congestive heart failure or shock and
combined end points were similar in elderly patients with and
without previous angina. CK-MB peak, number of Q wave
myocardial infarctions, ventricular fibrillation and left ventric-
ular dysfunction were also similar in elderly patients with and
without previous angina.
Protective effects of previous angina. Results obtained
from adult patients confirm published reports that previous
angina plays a protective role in patients with acute myocardial
infarction. Hirai et al. (15) demonstrated that left ventricular
ejection fraction was higher and wall motion abnormalities
rarer in patients with angina .1 week before acute myocardial
infarction than in those without angina. In addition, left
ventricular performance is better in patients with a history of
angina before acute myocardial infarction (16–18). A history
of angina was correlated with fewer episodes of reocclusion
after thrombolytic therapy and a reduced incidence of in-
hospital mortality (19). In another study (11), patients with
prodromal angina had a significantly smaller infarct size than
those without prodromal symptoms. More recently, Kloner et
al. (12) reported that previous angina has a beneficial effect on
in-hospital outcome after acute myocardial infarction. Finally,
Nakagawa et al. (20) demonstrated the protective effect of
angina pectoris in patients with reperfused anterior wall myo-
cardial infarction. To our knowledge, there are no reports on
the relation between effect of previous angina and myocardial
infarction in elderly patients.
Speculations on the protective mechanism of previous
angina. It is not known how previous angina exerts its protec-
tive role. Experimental studies have demonstrated that brief
episodes of ischemia trigger adaptive changes that protect the
myocardium from the effects of a subsequent, prolonged
ischemic insult. This phenomenon, now known as “ischemic
preconditioning” (10,21), has been extended to humans. Isch-
emic preconditioning in humans is defined as unstable angina
before acute myocardial infarction, percutaneous transluminal
coronary angioplasty and coronary artery bypass surgery with
intermittent cross-clamp fibrillation episodes (22). Induction
of stress protein (23,24), prostacyclin (25), adenosine release
(26), activation of adenose triphosphate–regulated K1 chan-
nels (27) and, more recently, norepinephrine (28) have been
involved as mediators of ischemic preconditioning. We re-
cently demonstrated (13) that ischemic preconditioning does
not occur in isolated hearts from senescent animals, whereas
exogenous norepinephrine produces preconditioning in both
adult and senescent hearts. Therefore, in the senescent heart
the absence of ischemic preconditioning may be due to the
absence of a mediator that triggers this protective endogenous
mechanism (13). This hypothesis is in agreement with studies
showing a reduction of norepinephrine release from cardiac
adrenergic terminals after ischemia and reperfusion in older
animals (29,30). In addition, Nitta et al. (31) suggested that the
greater vulnerability of aged hearts to ischemia may be due to
impaired protective mechanisms provided by heat shock pro-
teins. Ischemic preconditioning has been related to the induc-
tion of stress proteins (23,24); therefore, the age-related
absence of ischemic preconditioning could be due to the
reduction of heat shock protein synthesis observed in old
hearts during myocardial ischemia. The absence of this endog-
enous mechanism may explain why the aging heart is more
sensitive to electromechanical dysfunction induced by myocar-
dial ischemia (13).
Reperfusion-induced protective effect of previous angina.
One possibility why elderly patients did not benefit from
preinfarction angina is that they were less likely to have
reperfusion. Kloner et al. (32) reported that a history of angina
before a nonthrombolyzed acute myocardial infarction is a
marker of increased risk of infarct extension, recurrent isch-
emic pain and mitral regurgitation. However, a history of
previous angina was associated with a trend toward smaller
infarct size in patients who had spontaneous thrombolysis.
Spontaneous thrombolysis was equated with a CK-MB peak at
or within 15 h. In our study CK-MB was lower in adult (10.5 6
3.4) than in elderly (12.1 6 3.6) patients with previous angina.
However, both values were obtained within 15 h, suggesting
that both adult and senescent patients had similar reperfusion.
Thrombolytic therapy resulted in more rapid reperfusion and
smaller infarct size in patients with an acute myocardial
infarction preceded by unstable angina than in those without
preinfarction angina (33). The protective effect of previous
angina found in the group of elderly patients could have been
lost because fewer of these patients received thrombolytic
therapy than did adult patients. In other words, if the protec-
tive effect of preinfarction angina is related to the speed of
coronary reperfusion in patients receiving thrombolytic ther-
apy, the age-related absence of angina-induced protection
must be due to the reduction of the number of elderly patients
receiving thrombolytic therapy. In our logistic regression anal-
ysis, previous angina was protective in adult but not in elderly
patients, independent of thrombolytic therapy.
Limitations of the study. In general, data from retrospec-
tive studies should be viewed with caution (34). We established
criteria for patient inclusion before studying the patient record.
In addition to biased recall of events, data obtained from
hospital records may be incomplete. However, the major
limitation of this study is the number of patients. The statistical
power of detecting clinically significant differences in patients
with a myocardial infarction was 87%, under a type 1 error of
0.05 and an odds ratio as large as 2.60 (corresponding to a
mortality rate of 12% in patients without angina before
myocardial infarction). The power declined progressively to
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60%, 24% and 9%, with declining odds ratios of 2.00, 1.50, and
1.25. Moreover, if elderly patients are considered separately
(mortality rate 17%), the power further decreases with pro-
gressively declining odds ratios (i.e., from 57% to 33%, 13%
and 6%, respectively). The significance of our results should be
considered in the view of these findings. In addition, in the
adjusted model, the odds ratio of death in elderly patients
becomes 0.49, suggesting that there is a 50% improvement in
outcome in elderly patients who have preinfarction angina.
This finding means that the potential for ischemic precondi-
tioning remains in the elderly and that the age difference in
preconditioning is relative rather than absolute. Because most
physiologic modifications that occur during aging are progres-
sive and are therefore not “on–off,” the reduction of this
mechanism could have a progressive decline. Further prospec-
tive studies should be conducted to confirm the nonsignificant
difference in hospital outcomes between elderly patients with
or without previous angina before acute myocardial infarction.
Coronary angiography had not been performed in most of
the patients, and therefore the hypothetic difference in epicar-
dial collateral arteries between patients with and without
angina was not investigated. Ottani et al. (11) demonstrated
that prodromal angina limits infarct size in patients with a
complete absence of collateral circulation to the infarct-related
artery. Also Kloner et al. (12) demonstrated that the beneficial
effect on in-hospital outcomes of a history of previous angina
before acute myocardial infarction is independent of an in-
crease in collateral flow. However, experimental studies have
shown (35) that ischemic preconditioning is not a consequence
of increased collateral perfusion. According to experimental
studies (36), the clinical equivalent of ischemic preconditioning
is an episode of myocardial ischemia very near to subsequent
sustained myocardial ischemia. We defined previous angina as
an episode of chest pain that occurred at most 48 h before
myocardial infarction, independent of a history of chronic
angina. Nakagawa et al. (20) demonstrated that patients with
angina beginning .7 days before the onset of infarction had
better collateral coronary circulation than those with new
angina occurring #7 days of onset of infarction. However,
myocardial contractility was preserved after myocardial infarc-
tion in both groups of patients (20).
Another limitation of this study is the quantification of
ischemic episodes. Ambulatory ECG monitoring was not per-
formed in our study cohort before acute myocardial infarction,
and therefore episodes of silent ischemia, which are particu-
larly frequent in elderly patients, were not taken into account
in patient stratification (37,38). However, undetected episodes
of myocardial ischemia in elderly patients corroborate the
hypothesis of the absence of preconditioning in the aging
heart. In other words, if elderly patients had more silent
ischemic episodes than adults and preconditioning occurred,
they would have a lower mortality than adult patients. Alter-
natively, a high frequency of underestimated episodes of
myocardial ischemia in elderly patients could deplete the
mechanism responsible for the protection induced by precon-
ditioning. In the latter case, the absence of a protective effect
of angina in elderly patients is only apparent.
Conclusions and clinical implications. Previous angina
before acute myocardial infarction seems to confer protection
against in-hospital outcomes, such as death, congestive heart
failure or shock in adult patients, regardless of thrombolytic
therapy, antianginal drug use and demographic variables, such
as previous myocardial infarction; this effect seemed to be less
evident in elderly patients. It is feasible that these results are
related to the presence or absence of preconditioning. Pro-
spective studies are needed to verify the protective role of
previous angina before acute myocardial infarction and the
hypothetic loss of preconditioning in elderly patients. The
possible absence of preconditioning in the aging heart might
account in part for the higher mortality rate from acute
myocardial infarction observed in elderly patients.
We express our appreciation to Jean Gilder for editing the text.
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